Conduit Pharmaceuticals Granted Patent Approval For Autoimmune Diseases Treatment
By Karen Roman Conduit Pharmaceuticals Inc. (Nasdaq: CDT) said IP Australia approved a patent application for an activator targeting autoimmune diseases. This should open the path to approvals in other countries, Conduit said in a statement. “With up to 20...